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Nutritional adaptationAging is associated with alterations of lipid metabolism and increased prevalence of non alcoholic hepatic
steatosis. Nevertheless, themechanisms bywhich fat is accumulated in the liver during aging remain incomplete-
ly understood. In the present study, we investigated potential alterations that might contribute to the develop-
ment of hepatic steatosis with aging. To this end, we analyzed the expression and the subcellular localization
of key transcriptional factors involved in lipid metabolism such as ChREBP, Foxo1, Foxa2 and SREBP-1c in the
liver of 3- and 24-month oldWistar rats. In addition, we studied the intracellular redistribution of ChREBP in re-
sponse to fasting/refeeding transition. Old rats were characterized by hepatic steatosis, low serum ketone body
levels and postprandial hyperinsulinemia. These observations were paralleled by the cytoplasmic localization
and decreased expression of Foxa2, while ChREBP expression was markedly up-regulated and mainly localized
in the nucleus. Consequently, the expression of lipogenic and β-oxidation genes was up-regulated or down-
regulated, respectively. Besides, the intracellular redistribution of ChREBP in response to fasting/refeeding tran-
sition was also impaired in old animals. Additionally, a negative correlation between serum ketone body levels
and the nuclear localization of ChREBP was observed only in adult but not in old rats. Taken together, these
data suggest that an age-related dysfunctional adaptation of ChREBP, in response to changes in the nutritional
state, might contribute to the development of liver steatosis with aging.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
Aging is associated with an increase of adiposity, central and
peripheral insulin resistance and a set of metabolic disorders with a
common component: alteration of the caloric homeostasis and par-
ticularly the lipid metabolism. Consequently, hypertriglyceridemia
and non alcoholic hepatic steatosis are frequent in the aged popula-
tion (Gan et al., 2011). Despite extensive studies, themechanisms re-
sponsible for excessive lipid accumulation in liver are incompletely
understood (Trauner et al., 2010). However, obesity, insulin resis-
tance and more recently the failure of leptin action have beenlare.
, Faculty of Chemistry, CRIB,
n.
, nilda.gallardo@uclm.esconsidered among the primary metabolic disorders for the develop-
ment of hepatic steatosis (Eriksson et al., 1986; Marchesini et al.,
1999; Fishman et al., 2007).
Hepatic steatosismay arise from an imbalance between lipid deposi-
tion (from dietary fatty acid/glucose, peripheral lipolysis, and de novo
lipogenesis) and elimination (via fatty acid oxidation and VLDL-
triacylglyceride secretion) (Anderson and Borlak, 2008). These
metabolic pathways are under tight regulation by the nutritionally
regulated transcription factors ChREBP, SREBP-1c, Foxo1 and Foxa2,
among others transcription factors. ChREBP and SREBP-1c are key
lipogenic transcription factors responsible for the induction of gene
encoding enzymes involved in fatty acid and triacylglyceride synthesis
in the liver (Horton et al., 2002; Dentin et al., 2004). Accordingly, in-
creased levels of ChREBP or SREBP-1c in the liver have been associated
with hepatic steatosis in human and rodent models with extreme obe-
sity, insulin resistance and type 2 diabetes (Shimomura et al., 1999;
Dentin et al., 2006; Hurtado del Pozo et al., 2011). Furthermore, the
subcellular distribution of ChREBP between the nucleus and cytosol is
controlled by different metabolites including xylulose 5-phosphate,
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(Kabashima et al., 2003; Arden et al., 2012; Dentin et al., 2012;
Díaz-Moralli et al., 2012; Nakagawa et al., 2013).
The forkhead transcription factors, Foxo1 and Foxa2, belong to a su-
perfamily of proteins that play a major role in regulating the metabolic
functions of the liver (Le Lay and Kaestner, 2010). In fasting, Foxo1 in-
creases the hepatic glucose production upregulating gene expression
of two gluconeogenic enzymes, phosphoenolpyruvate carboxykinase
and glucose-6-phosphatase catalytic subunit (Zhang et al., 2006). On
the other hand, Foxa2 activates genes involved in fatty acid oxidation
and ketone body production (Wolfrum et al, 2004). In the fed state,
insulin stimulates the phosphorylation of Foxo1 and Foxa2 by Akt,
resulting in nuclear exclusion and inhibition of their transcriptional ac-
tivity (Biggs et al., 1999; Wolfrum et al., 2004). In this sense, in insulin-
resistant or hyperinsulinemicmice, Foxa2 is inactive and localized in the
cytoplasm leading to lipid accumulation in the liver (Wolfrum et al.,
2004), while in transgenic mice expressing constitutively active Foxo1
in the liver, de novo hepatic lipogenesis is decreased (Zhang et al.,
2006). Despite the extensive knowledge on these transcription factors,
the role of ChREBP, Foxa2, Foxo1 and SREBP-1c in the physiopathology
of non alcoholic hepatic steatosis with aging remains to be fully
elucidated.
AgedWistar rats, as humans and other rodent models, present an
increase of adiposity and develop insulin resistance (Escrivá et al.,
1997, 2007). However, the insulin resistance of old rats is selective
or tissue-speciﬁc, and does not uniformly develop and affect all
target tissues and intracellular pathways at the same time. In fact,
our previous studies demonstrated that the insulin signaling path-
way that promotes glucose metabolism is impaired in visceral
adipose tissue and skeletal muscle (Escrivá et al., 2007; de Solís
et al., 2012), but not in the liver of old rats (Serrano et al., 2009). As
a result, overnight fasted old Wistar rats are able to maintain normal
serum glucose and insulin levels, but during oral glucose test or
under euglycemic/hyperinsulinemic clamp conditions these animals
need higher concentrations of insulin to cope with glucose, demon-
strating its insulin resistance (Escrivá et al., 1997, 2007). Further-
more, several studies in humans and rodent models have shown
that excessive lipid accumulation in the liver is not invariably associ-
ated with hepatic insulin resistance (Farese et al., 2012).
In this context, we have recently reported that old Wistar rats, be-
sides hepatic steatosis, develop a mild perisinusoidal ﬁbrosis associated
with signs of oxidative stress and inﬂammation (Horrillo et al., 2013),
but the involvement of critical transcription factorsmediators of insulin
and glucose signaling that sense fuel availability, such as ChREBP, Foxa2,
Foxo1 and SREBP-1c, in age-associated hepatic steatosis was not
addressed. In the present study, we hypothesized that alterations in
these transcription factors underline the development of hepatic
steatosis in old rats. To this end, we measured the expression levels
and the subcellular distribution of these transcription factors, as well
as, the expression of some target genes encoding enzymes of lipid
synthesis and oxidation in liver with aging. We have also analyzed the
adaptation of ChREBP in response to fasting and refeeding with aging,
and the correlation among serum ketone body levels and the hepatic
mRNA levels and nuclear protein localization of ChREBP in adult and
old rats.
2. Materials and methods
2.1. Animals
Experiments were performed in male 3- and 24-month-old
Wistar rats from our in-house colony (Centre of Molecular Biology,
Madrid, Spain). Animals were housed in climate-controlled quarters
with a 12-h light cycle and fed ad libitum standard laboratory chow
and water. They were handled according to the European Union laws
and the National Institute of Health (NIH) guidelines for animal care.The Institutional Advisory Committee of Bioethics and Animal Care
reviewed and approved all the experimental procedures, and special
care was taken to minimize animal suffering and to reduce the number
of animals used.
2.2. Analytical procedures
All the animals were fasted 16 h, including the overnight period,
before being sacriﬁced by decapitation. Liver and visceral fat depots
were carefully dissected and weighed. Then, tissues were ﬂash frozen
in liquid nitrogen and stored at−70 °C until use. Serum samples were
obtained by blood centrifugation and stored at −70 °C until used.
When examining the adaptation to the changes in the nutritional
state, food was removed for 36 h prior to re-feeding animals for 3 h, be-
fore euthanizing. In these animals serum samples were subsequently
obtained in fasted or fed state.
Serum determinations were measured as previously described
(Gallardo et al., 2007). Triacylglycerides (TAG) and total cholesterol
levels were determined by enzymatic kits from Stanbio Laboratory
(Boerne, TX). Non-steriﬁed fatty acid (NEFA) levels were measured
with an enzymatic assay fromWako Chemicals (Neuss, Germany) and
glucose levels were determined using AmplexRed glucose/Glucose
Oxidase Assay Kit (Molecular Probes, Inc., Eugene, OR). Total serum ke-
tone body (KB) levels were quantiﬁed by an enzymatic kit from Wako
Chemicals (Neuss, Germany). Serum insulin and leptin levelsweremea-
sured by ELISA using rat speciﬁc kits from SPI-Bio (France), following
the instructions of the manufacturer.
2.3. Oral glucose tolerance test
Oral glucose tolerance test (OGTT) was performed in overnight
fasted rats as previously described (Escrivá et al., 2007). Brieﬂy, 30% glu-
cose solution was administered intragastrically (2 g/kg of body weight)
and blood samples were obtained from the tail tip at 0, 15, 30, 60 and
120 min after glucose administration. Glucose levels were measured
immediately using an Accutrend Glucose Analyzer (Roche Diagnostics
Corp., Indianapolis, IN). Serum insulin levels were assayed as described
above. Overall changes in glucose and insulin during glucose tolerance
test were calculated as the area under the curve (AUC) using the
GraphPad prism version 6.01 for Windows (GraphPad Sotfware). The
ratio of glucose AUC to insulin AUC was used as an index of whole
body insulin sensitivity.
2.4. Hepatic lipid measurements and staining techniques
Total lipids were extracted from liver (100 mg) as previously
described (Gallardo et al., 2007). The hepatic TAG and cholesterol
content were analyzed with the same enzymatic kits used in serum
analysis. For histological studies, liver specimens were taken imme-
diately after the rats were sacriﬁced, incubated in ﬁxation solution
containing 4% paraformaldehyde and cryoprotected in 30% sucrose.
6 μm serial frozen sections were taken in a cryomicrotome (Microm)
and mounted onto gelatin-coated slides. Lipid staining was per-
formed using the Oil Red O soluble dye (Sigma) that stains neutral
lipids with an orange-red tint. Liver sections were stained as de-
scribed (Goodpaster et al., 2000).
2.5. Preparation of total, nuclear and cytoplasmic extracts from liver and
immunoblot analysis
100 mg of frozen liver was ground in the frozen state under liq-
uid N2 before homogenization (2 ml buffer/g tissue) in Henseleit
buffer with 1 mM PMSF, 2 mM Na3VO4, 10 μg/mL leupeptin,
10 μg/mL aprotinin and 1 μg/mL pepstatin, using a manual Dounce
homogenizer, and centrifuged at 800 ×g for 5 min at 4 °C to produce
a total extract. NE-PER nuclear and cytoplasmic extraction reagents
Table 1
Body weight and serum metabolic parameters in overnight fasted 3- and 24-month-old
rats.
3-month 24-month
Body weight (g) 363 ± 7 672 ± 17*
Visceral fat (g) 9.9 ± 2.7 26.7 ± 2.8*
Serum glucose (mmol/L) 4.5 ± 0.2 5.0 ± 0.1
Serum insulin (ng/ml) 1.32 ± 0.2 1.36 ± 0.2
Serum leptin (ng/ml) 4.8 ± 0.8 16.5 ± 2.6*
Serum TAG (mg/dl) 90 ± 4 171 ± 8**
Serum cholesterol (mg/dl) 59 ± 2 138 ± 8**
Serum NEFA (mmol/L) 1.01 ± 0.04 1.08 ± 0.03
Serum ketone bodies (mmol/L) 0.72 ± 0.09 0.31 ± 0.01*
Data were obtained from 8 to 10 rats per group and represent mean ± SEM. Biochemical
determinations were made in duplicate (*p b 0.05; **p b 0.005 compared to 3-month-old
rats). TAG: triacylglycerides; NEFA: non-steriﬁed fatty acid.
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and cytoplasmic extracts from liver of 3- and 24-month old Wistar
rats.
100 μg of protein from total and cytoplasmic extracts and 50 μg of
protein from nuclear extract were separated under reducing conditions
in 7.5% SDS-PAGE. Proteins were transferred to nitrocellulose sheets
(0.2 μm) (Bio-Rad, Spain) and incubated overnight at 4 °C with the
corresponding primary antibody followed by incubation at room
temperature for 30 min with secondary antibody conjugated with
horseradish peroxidase. Primary rabbit polyclonal antibodies were
anti-SREBP-1c (1:200; sc-8984, Santa Cruz Biotech., CA), anti-ChREBP
(1:200; ab-30681, Abcam, Cambridge, UK), anti-ChREBP-ChIP grade
(1:200; ab92809, Abcam, Cambridge, UK), anti-Foxo1a (1:500; ab-
39670, Abcam, Cambridge, UK), anti-p-S319-Foxo1a (1:1000; ab-
47326, Abcam, Cambridge, UK), anti-Foxa2 (1:500; ab-23630, Abcam,
Cambridge, UK), anti-GW182 (1:500; ab-87541, Abcam, Cambridge,
UK) and secondary antibody goat anti-rabbit conjugatedwith horserad-
ish peroxidase (1:5000; ref-172-1019, Bio-Rad, Spain). Primary mouse
monoclonal antibodies were anti-lamin A/C (1:1000; MAB-3538,
Chemicon International, Millipore Corporation), anti-β-actin (1:5000;
ab-8226, Abcam, Cambridge, UK) and secondary antibody goat anti-
mouse conjugated with horseradish peroxidase (1:5000; ref-170-
6516, Bio-Rad, Spain).
The immunocomplexes formed were visualized using the
ECL Western-blotting detection kit (Amersham Biosciences, Inc.,
Piscataway, NJ) with a G-Box Densitometer, and bands were quantiﬁed
by scanning densitometry with exposure in the linear range using Gene
Tools software (Syngene, Cambridge, UK), and normalized to that of β-
actin. The densitometric relative levels of pS319-Foxo1 were normal-
ized to the corresponding amount of Foxo1 protein mass in the same
sample. Liver samples (total extracts, nuclear or cytosolic extracts)
from 3- and 24-month old rats were run on the same gel to allow a
direct comparison between the two age-groups. β-actin was used as
control for protein loading. GW182 and lamin A/C were used as cyto-
plasmic and nuclear markers, respectively.2.6. RNA extraction and real-time RT-PCR
Total RNAwas isolated from liver as described (Gallardo et al., 2007).
Relative quantitation of ChREBP, Foxo1a, Foxa2, SREBP-1c, acetyl-CoA-
carboxylase-α (ACCα), fatty acid synthase (FAS), diacylglycerol
acyltransferase-1 (DGAT-1), diacylglycerol acyltransferase-2 (DGAT-
2), microsomal transfer protein (MTTP), peroxysome proliferator
activating receptor-α (PPAR-α), PPARγ-coactivator-1α (PGC-1α) and
carnitine palmitoyl transferase 1a (CPT-1a) mRNA expression was
performed by TaqMan real-time PCR according to the manufacturer's
protocol on anABI PRISM 7500 FAST Sequence Detection System instru-
ment and software (PE Applied Biosystems, Foster City, CA), using Pre-
Developed TaqMan Assay Reagents (PE Applied Biosystems) (Supple-
mentary Table 1). To normalize the amount of sample cDNA added to
the reaction, ampliﬁcation of endogenous control 18S rRNAwas includ-
ed in separatewells as real-time reporter. TheΔΔCTmethodwas used to
calculate the relative differences between experimental conditions and
control groups as fold change in gene expression (Livak and Schmittgen,
2001).2.7. Statistics
Data are expressed as mean ± SEM. The signiﬁcance of differences
between two groups was determined by unpaired Student's t-test. Cor-
relation analysis was determined by Pearson's correlation coefﬁcient
test (r). Statistical analysis was performed using the GraphPad Prism
version 6.01 for Windows (GrapPad Software). Differences were
considered signiﬁcant at p b 0.05.3. Results
3.1. Biological characteristics of 3- and 24-month old rats
Body weight and metabolic parameters of the animals used in the
present experiments are shown in Table 1. Old Wistar rats exhibit
increased body weight, visceral fat mass and serum leptin levels. Over-
night fasted old rats had normal serum glucose and insulin levels, and
no signiﬁcant effect of age was also observed in NEFA levels. Neverthe-
less, old animals became hypertriglyceridemic and hypercholesterol-
emic, but according to our earlier observations (Escrivá et al., 1997),
the levels of ketone bodies were signiﬁcantly decreased compared
with adult mature rats (Table 1). Changes in glucose and insulin levels
during OGTT are shown in Fig. 1. The increment of glucose was similar
for the two age groups indicating that glucose tolerance was not modi-
ﬁed during aging. In contrast, the curve for insulin in response to the
glucose load increased signiﬁcantly in the old rats, suggesting the devel-
opment of peripheral insulin resistance. Consistentwith this, the insulin
sensitivity index, calculated as the ratio of glucose AUC to insulin AUC,
decreased signiﬁcantly in old rats conﬁrming our previous observations
(Escrivá et al., 2007).
3.2. Increased lipid content in liver from old rats
As shown in Fig. 2A, oldWistar rats accumulated signiﬁcantly higher
levels of TAG and cholesterol in the liver. The excessive accumulation of
neutral lipids in the livers from old rats was conﬁrmed upon Oil Red O
staining, while lipid droplet staining was absent in the young animals
(Fig. 2B). Moreover, the liver-to-body weight ratio (%) was increased
in old comparedwith adult rats (3.27± 0.13 vs. 2.81±0.06, respective-
ly; n = 10, p b 0.05).
3.3. Up-regulation of hepatic ChREBP expression in old rats
To determine whether aging alters the expression levels of ChREBP,
Foxa2, Foxo1 and SREBP-1c in the liver of rats, we measured the mRNA
and total protein levels of these transcription factors. As can be seen in
Fig. 3A, we found a ~2.0 fold increase in the relative mRNA levels of
ChREBP in old rats, while there was no change in the mRNA levels of
SREBP-1c between the two age-groups. On the other hand, we observed
that the mRNA levels of the FKH factors, Foxo1 and Foxa2, were also al-
tered in the liver from old rats.While the transcript levels of Foxo1were
slightly increased ~1.6 folds, Foxa2 mRNA levels were decreased ~2.0
folds in old compared with adult mature rats (Fig. 3A). Immunoblot
analysis was used to determine the protein abundance of these tran-
scription factors in total liver extracts from 3- and 24-month old rats.
Fig. 3B shows that in parallel to the mRNA levels, ChREBP total protein
levels were signiﬁcantly increased, while Foxa2 protein levels were de-
creased in the liver from old rats. However, the total protein levels of
Fig. 1.Oral glucose tolerance test in 3- and 24-month oldWistar rats. Evolution of blood glucose and plasma insulin concentrations in overnight fasted rats after administration of an oral
glucose load as indicated in Materials and methods. Overall changes in glucose and insulin during glucose tolerance test were calculated as the area under the curve (AUC). The ratio of
glucose AUC to insulin AUC was used as an index of whole body insulin sensitivity. Values are mean ± SEM of 5–7 rats per group, 3-month (O) and 24-month (∇) old rats (*p b 0.05,
**p b 0.01 vs. 3-month old rats).
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(Fig. 3B).
3.4. Effect of aging in the expression of genes involved in hepatic lipid
metabolism
Next, we have analyzed themRNA levels of several hepatic genes in-
volved in lipidmetabolismunder the control of the transcription factorsFig. 2. Increased fat accumulation in liver of old rats. A, triacylglycerides (TAG) and cholestero
methods. B, representative Oil Red O stained liver sections from overnight fasted 3- and 24-mo
magniﬁcation shows lipid droplets 100×. Results are the mean ± SEM of 10 rats per group (*pmentioned above. In agreement with the observed changes in hepatic
ChREBP expression in aging rats, the mRNA levels of the lipogenic en-
zymes ACC-α and FAS were signiﬁcantly up-regulated; ~2.0 and ~3.1
folds respectively, in old rats (Table 2). We have also observed that
aging caused a signiﬁcant increase in the mRNA abundance of both,
DGAT1 and DGAT2, and MTTP (Table 2), suggesting an increased ester-
iﬁcation and VLDL-TAG secretion in aged rats. Finally, we determined
the expression levels of PPARα, PGC-1α and CPT-1a involved in lipidl content in liver from 3- and 24-month-old rats measured as described in Materials and
nth oldWistar rats showing neutral lipid staining. Original magniﬁcation 40×. Inset higher
b 0.05, ⁎⁎⁎p b 0.001 compared to 3-month-old rats).
Fig. 3. Increased expression levels of ChREBP in the liver of aging rats. A, real-time PCR analysis formRNA levels of transcription factors involved in lipidmetabolism. B, protein levels from
liver total extract (100 μg) was resolved by SDS-PAGE and immunoblotted for ChREBP, SREBP-1c, Foxo1 and Foxa2. β-actin was used as control for protein loading and for densitometric
normalization. Representative immunoblots of two individual animals per age group are shown. The relative total levels of the transcription factorswere quantiﬁed by scanning densitom-
etry. Data are the means ± SEM of 5 separate determinations per age group (*p b 0.05 vs. 3-month old rats).
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~1.4 and ~2.6 folds, respectively, the expression levels of CPT-1a, the
most important enzyme for controlling the availability of long-chain
acyl-CoA for mitochondrial fatty acid oxidation, was markedly de-
creased ~2.5 folds in old rats (Table 2).
3.5. Effect of aging in the hepatic subcellular distribution of ChREBP, Foxo1,
Foxa2 and SREBP-1c
In order to study the effect of aging on the hepatic subcellular local-
ization of these transcriptions factors, we analyzed their relative distri-
bution between cytoplasm and nucleus isolated from the liver of
overnight fasted 3- and 24-month old rats. Interestingly, we foundTable 2
Changes in gene expression of several genes involved in lipidmetabolism in the liver in 3-
and 24-month-old Wistar rats using 18S rRNA as the invariant control.
Gene 3-month 24-month
Lipogenesis
ACC-α 1 ± 0.1 2.0 ± 0.1**
FAS 1 ± 0.2 3.1 ± 0.3**
Lipid esteriﬁcation and secretion
DGAT-1 1 ± 0.01 4.0 ± 0.1**
DGAT-2 1 ± 0.04 3.1 ± 0.6**
MTTP 1 ± 0.05 1.9 ± 0.2**
Lipid oxidation
PPARα 1 ± 0.1 1.4 ± 0.1*
PGC-1α 1 ± 0.1 2.6 ± 0.1**
CPT-1a 1 ± 0.07 0.4 ± 0.05**
Data are themean ± SEM of 4 to 5 separate determinations, made in triplicate (*p b 0.05;
**p b 0.005 compared to 3-month-old rats).that the nuclear protein levels of ChREBP in overnight fasted old rats
were signiﬁcantly increased ~3 folds as compared with adult rats
(Fig. 4, A and C). Our data also show that, the cytosolic protein levels
of ChREBP decreased ~6 folds in old compared to adult control rats
(Fig. 4, B and C). These ﬁndings are in line with recent data suggesting
that the nuclear localization of ChREBP can be inhibited in isolated
hepatocytes incubated with ketone bodies (Nakagawa et al., 2013).
Thus, as serum ketone body levels in old rats are signiﬁcantly lower
than in adult rats (Table 1), this would explain the high nuclear content
of ChREBP found in the liver from old rats.
On the other hand, the nuclear protein levels of Foxo1 and Foxa2
were signiﬁcantly decreased in overnight fasted old rats (Fig. 5A). Par-
ticularly, the content of Foxa2 in the nuclear fraction of liver extracts
from old rats was barely visible (Fig. 5A) and decreased ~4.5 folds as
compared to adult rats (Fig. 5D), and this was followed by a marked in-
crease in the cytosol in old rats (Fig. 5, B and D). In addition, there is a
slight decrease in the cytosolic protein content of Foxo1 (Fig. 5B),
while the phosphorylated Foxo1 levels increased ~2.1 folds in old rats
(Fig. 5, B and C). Finally, the nuclear protein levels of the SREBP-1c
(68 kDa) remain unchanged with aging (Supplementary Fig. 1).
3.6. Dysfunctional adaptation of hepatic ChREBP in response to fasting and
feeding in aging rats
Because the inhibition of nuclear localization of ChREBP is closely
related with the production of ketone bodies (Nakagawa et al., 2013),
we sought to analyze if increasing serum ketone body levels in old
rats would decrease the nuclear localization of ChREBP. To this end, as
serum ketone bodies are increased upon prolonged starvation, we
studied the subcellular distribution of ChREBP in response to changes
Fig. 4. Aging increases the nuclear levels of ChREBP in the liver of old rats. A, protein from nuclear extracts (50 μg) or B, cytoplasmic extracts (100 μg) were resolved by SDS-PAGE and
immunoblotted for ChREBP. β-actin was used as control for protein loading and for densitometric normalization. Lamin A/C and GW182 were used as nuclear and cytoplasmic markers,
respectively. Representative immunoblots of two individual animals per age group are shown. C, the relative levels of ChREBP in each subcellular fractionwas quantiﬁed by scanning den-
sitometry. Data are the means ± SEM of 5 separate determinations per age group (**p b 0.005 vs. 3-month old rats).
14 A. Salamanca et al. / Experimental Gerontology 69 (2015) 9–19in the nutritional state, in rats fasted for 36 h and then re-fed during 3 h
before killing the animals. As expected, upon a prolonged fasting, there
was amarked increase in serumketone body levels in 3- and 24-month-
old rats (1.94± 0.2 vs. 1.51 ± 0.17 mmol/L, respectively; n= 4–6; n.s.)
(Table 3), compared to the levels of overnight fasted adult and old ani-
mals (0.72 ± 0.09 vs. 0.31 ± 0.01 mmol/L, respectively; n = (8–10;
*p b 0.05)) (Table 1). Accordingly, we found decreased mRNA
(Fig. 6A) and nuclear protein levels of ChREBP (Fig. 6B) in liver from
adult rats. In contrast, despite the high increase in serum ketone bodies
levels in old rats reaching similar concentration than those in adult rats
upon 36 h starvation, the mRNA (Fig. 6A) and nuclear protein localiza-
tion of ChREBP (Fig. 6B) remain high in the liver of aging rats. Taken to-
gether, these data might suggest that the inhibition of hepatic nuclear
localization of ChREBP by ketone bodies is impaired in old rats.
On the other hand, in response to re-feeding, there was a signiﬁcant
increase in themRNAand nuclear protein levels of ChREBP (Fig. 6, A and
B) in adult rats, consistent with the marked decrease in ketone body
levels ~13.8 folds (Table 3) in these animals. In contrast, the transition
from fasting to re-feeding in old rats induced a small, not signiﬁcant, in-
crease over the already highmRNA andnuclear protein levels of ChREBP
(Fig. 6, A and B) that parallels the low decrease ~2.2 folds in serum
ketone body levels found in aging rats (Table 3). In addition, to analyze
the association between serum ketone body levels and hepatic ChREBP,
we performed correlation analysis. As illustrated, a signiﬁcant negative
correlation between serumketone body levels and hepaticmRNA levels
(r =−0.903, p b 0.003; Fig. 6A) and hepatic nuclear protein levels ofChREBP (r = −0.827, p b 0.003; Fig. 6C) was only observed in adult
rats, whereas no correlation was found in old rats (Fig. 6, A and C).
Finally, it is worthy to note that the increment on serum glucose, upon
re-feeding, was similar for the two age groups of rats, but serum insulin
concentrations were signiﬁcantly higher in old compared with adult
rats (Table 3). These data sustain that prolonged fasting exacerbates
the insulin resistance in old rats and that higher insulin levels were
required to maintain normal levels of fasting serum glucose in aging
rats.4. Discussion
Aging is a physiological condition characterized by certainmetabolic
disorders associated with obesity, insulin resistance, and dyslipidemia
that give rise to hepatic steatosis (Trauner et al., 2010; Gan et al.,
2011). Among the mechanisms that lead to hepatic steatosis are
increased lipogenesis and reduced β-oxidation (Diraison et al., 2003;
Tamura and Shimomura, 2005). Thus, our aim in the present study
was to investigate whether alterations in the expression and/or subcel-
lular distribution of ChREBP, Foxa2, Foxo1 and SREBP-1c, key transcrip-
tions factors involved in liver lipid metabolism, underline the
development of steatosis with aging, a physiological model character-
ized by mild increased adiposity and insulin resistance as compared
with models with extreme obesity, insulin resistance and type 2
diabetes as the ob/ob mice and/or diet-induced obese mice and rats
Fig. 5. Low levels of FKH proteins in the hepatic nuclear fraction from old rats. A, protein from liver nuclear extracts (50 μg) or B, cytoplasmic extracts (100 μg)were resolved by SDS-PAGE
and immunoblotted for p-S319-Foxo1, Foxo1 and Foxa2. β-actin was used as control for protein loading and for densitometric normalization, except in the case of pS-Foxo1 that Foxo1
mass was used for densitometric normalization. Lamin A/C and GW182 were used as nuclear and cytoplasmic markers, respectively. Representative immunoblots of two individual an-
imals per age group are shown. C, represents the relative levels of hepatic Foxo1 and D, hepatic Foxa2 in each subcellular fraction quantiﬁed by scanning densitometry. Data are the
means ± SEM of 5 separate determinations per age group (*p b 0.05 vs. 3-month old rats).
15A. Salamanca et al. / Experimental Gerontology 69 (2015) 9–19(Shimomura et al., 1999; Iizuka et al., 2004; Wolfrum et al., 2004;
Dentin et al., 2006).
We show that hepatic TAG and cholesterol content were markedly
increased in liver from old animals. Besides, we also show that old
rats, in order to maintain normoglycemia, need higher concentrations
of insulin compared with adult rats upon an OGTT, a situation thatTable 3
Serum metabolic parameters in 3- and 24-month-old rats in response to fasting and feeding.
3-month
36 h fast 3 h fed
Serum glucose (mmol/L) 4.02 ± 0.1 6.33 ± 0
Serum insulin (ng/ml) 0.42 ± 0.05 2.48 ± 0
Serum NEFA (mmol/L) 0.68 ± 0.1 0.43 ± 0
Serum total KB (mmol/L) 1.94 ± 0.2 0.14 ± 0
Data were obtained from 4 to 6 rats per age group and represent mean ± SEM. Biochemical de
rats); (+p b 0.05; ++p b 0.005; +++p b 0.001 compared to same age fed). NEFA: non-steriﬁedwas also observed when animals were fed after prolonged fasting.
These data demonstrate the presence of postprandial hyperinsulinemia
as a result of the insulin resistance with aging. As the insulin resistance
appears in visceral adipose tissue and skeletal muscle (Escrivá et al.,
2007; de Solís et al., 2012), but not in liver of old rats (Serrano et al.,
2009), this selective or tissue-speciﬁc peripheral insulin resistance24-month
36 h fast 3 h fed
.34++ 5.24 ± 0.8 6.74 ± 1.32++
.31++ 2.15 ± 0.32*** 4.15 ± 0.19**,++
.05++ 0.71 ± 0.06 0.56 ± 0.09
.02+++ 1.51 ± 0.17 0.68 ± 0.04***,+
terminations were made in duplicate (**p b 0.005; ***p b 0.001 compared to 3-month-old
fatty acid; KB: ketone bodies.
Fig. 6.Dysfunctional adaptation of ChREBP in response to fasting/refeeding transition in the liver of old rats. A, ChREBPmRNA levels and correlation analysis between serum ketone bodies
and hepatic mRNA levels in 36 h fasted and after 3 h refeeding in 3-month (●) and 24-month (▼) old rats. B, nuclear content of ChREBP in 36 h fasted and after 3 h refeeding in adult and
old rats. Protein fromnuclear liver extracts (50 μg)was resolved by SDS-PAGE and immunoblotted for ChREBP.β-actinwas used as control for protein loading. GW182 and lamin A/Cwere
used as cytoplasmic and nuclear markers respectively. Representative immunoblots of two individual animals per age group are shown. The relative nuclear levels of ChREBPwere quan-
tiﬁed by scanning densitometry. C, correlation analysis between serum ketone bodies and nuclear protein levels of ChREBP in 36 h fasted and after 3 h refeeding in 3-month (●) and 24-
month (▼) old rats. Individual data derived from each adult and old rat were used for correlation analysis. Data are the means ± SEM of 4–5 separate determinations per age group
(*p b 0.05 vs. 3-month old rats).
16 A. Salamanca et al. / Experimental Gerontology 69 (2015) 9–19could well contribute to cause hepatic steatosis by increasing postpran-
dial availability of FA and glucose for hepatic de novo lipogenesis in
aging rats probably due to altered nutrient handling by the insulin resis-
tant peripheral tissues (Otero et al., 2014). Indeed, it has been shown
that skeletal muscle insulin resistance in human aging promotes in-
creased hepatic steatosis by decreasing postprandial glucose storage
away from muscle glycogen and increasing glucose delivery toward
de novo lipogenesis in the liver (Flannery et al., 2012) and that the
excessive lipid accumulation in the liver is not invariably associated
with hepatic insulin resistance (Farese et al., 2012).
At molecular level, we found, for the ﬁrst time, a signiﬁcant decrease
in the expression and nuclear content of Foxa2, while the cytoplasmic,
inactive, Foxa2 protein levels were increased in the liver from insulin-
resistant old rats. These data are in line with previous observations in
hyperinsulinemic insulin-resistant ob/obmice and diet-induced obese
mice, characterized by the cytoplasmic localization and inactivation ofFoxa2 in the liver (Wolfrum et al., 2004). Therefore, the persistent post-
prandial hyperinsulinemia in old animals reported herein might stimu-
late the cytoplasmic translocation of Foxa2 impairing ketogenesis in the
liver in aging rats. This suggestion is supported by several lines of evi-
dence. First, it has been previously reported that prolonged exposure
of primary hepatocytes to insulin decreased ketogenesis (Agius et al.,
1986) and reduced the transcript levels of CPT-1a whereas increased
hepatic lipogenic program (Liu et al., 2009). Secondly, a decreased keto-
genesis in primary hepatocytes incubated with oleate in aging rats has
been reported (Sastre et al., 1996). Finally, in agreement with these
data we found a signiﬁcant down-regulation of hepatic CPT-1a gene
expression, increased expression of genes involved in lipogenesis such
as ChREBP, ACC- α and FAS, and decreased serum ketone body levels
in old compared with adult rats.
Akt-mediated phosphorylation of Foxo1 in the fed state results in its
exclusion from the nucleus and inhibition of its transcriptional activity
Fig. 7. Schematicmodel illustrating the relationship between circulating insulin and ketone bodies and thehepatic nuclear localization of ChREBP. Aged rats present increased insulin levels
compared with adult rats after prolonged fasting and a clear postprandial hyperinsulinemia. In these circumstances it is interesting to note the deregulation in the fasting–feeding mod-
ulation of ketone body levels with aging. Consistent with this deregulation, nuclear localization of ChREBP is increased in the liver of aged rats and regulation of ChREBP by ketone bodies
appears to be affected. As a result, the lipogenesis and fat accumulation in the liver of the aged rats are increased.
17A. Salamanca et al. / Experimental Gerontology 69 (2015) 9–19(Biggs et al., 1999). Nevertheless, we have previously reported in-
creased basal Akt activity in livers from overnight fasted old rats
(Serrano et al., 2009) that may well explain the high phosphorylation
levels of Foxo1 in the cytoplasm, leading to the inhibition of Foxo1 tran-
scriptional activitywith aging. Thus, it might be suggested that the cyto-
plasmic localization of Foxo1 could be linked to the increased total and
nuclear protein levels of ChREBP found in old rats. In fact, it has been re-
ported that liver speciﬁc Foxo1 knockout mice enhanced total protein
levels of ChREBP and recruitment to its target gene promoter (Ido-
Kitamura et al., 2012).
SREBP-1c has been considered a key mediator for insulin resistance
and hepatic steatosis (Moon et al., 2012) and overproduction of
nuclear-active SREBP-1c inhibited IRS2/PI3K/AKT pathway, decreased
glycogen synthesis and promoted lipogenesis in the liver (Ide et al.,
2004). In this work, the expression of SREBP-1c and the levels of its
mature form in the nucleus of the overnight fasted rats were not altered
with aging. Although SREBP-1c is responsible for the induction of
lipogenic genes ACC-α and FAS, which expression is also increased
synergistically by ChREBP (Dentin et al., 2004), this transcription factor
does not seem to be involved in the development of the hepatic
steatosis with aging. In line with this suggestion, it has been shown
that ChREBP, but not SREBP-1c, was increased in the liver nuclear
fraction in 24 h fasted ob/ob mice (Dentin et al., 2006). Nevertheless,
the role of SREBP-1c in hepatic steatosis with aging needs further
work before a ﬁnal conclusion may be drawn.
It is known that ChREBP−/−mice resulted in decreased expression of
key lipogenic enzymes, leading to a signiﬁcant decrease in hepatic fatty
acid synthesis rates compared to wild-type mice (Iizuka et al., 2004).
Likewise, an important reduction in hepatic lipogenesis was also
shown in double deﬁcient ob/ob-ChREBP−/−mice (Iizuka et al., 2006).
Collectively, these data suggested a potential role of ChREBP in the de-
velopment of hepatic steatosis. In fact, recent data show that ChREBP
overexpressing mice fed a high-fat diet are characterized by increased
expression of genes involved in lipogenesis, fatty acid esteriﬁcation
and TAG mobilization, such as ACC-α, FAS, DGAT-1 and MTTP, leadingto hepatic steatosis (Benhamed et al., 2012). In this study, we show
that the increased levels and nuclear localization of ChREBP in livers
from old rats was paralleled by the signiﬁcant up-regulation of their
lipogenic target genes ACC-α and FAS, as well as DGAT-1, DGAT-2 and
MTTP. According to this data and because the hepatic MTTP expression
is enhanced by Foxo1 and Foxa2 (Wolfrum and Stoffel, 2006; Kamagate
et al., 2008), it is tempting to speculate that the up-regulation and nu-
clear localization of ChREBP, and its probably increased transcriptional
activity, would increase MTTP expression reported herein in old rats,
compensating in this way for the inactivation of Foxo1 and Foxa2 that
should lead to the downregulation of MTTP expression. In this regard,
it has been shown that the heterodimer formed by ChREBP and Max-
like protein X (ChREBP-Mlx), the principal transcription factor regulat-
ing glucose-responsive lipogenic enzyme genes in the liver, increased
signiﬁcantly the hepatic expression of MTTP (Ma et al., 2006). Thus,
the sustained nuclear localization of ChREBP in the livers from old rats
might increase de novo lipogenesis, lipid deposition and VLDL-TAG se-
cretion as demonstrated by the hepatic steatosis and marked
hypertryglyceridemia in old rats.
Our study uncovered a novel ﬁnding by demonstrating for the ﬁrst
time the permanent nuclear localization of ChREBP independent of the
nutritional state in old rats. It has been reported that xylulose 5-
phosphate, glucose 6-phosphate and fructose 2,6-biphosphate modu-
lates gene expression and translocation of ChREBP to the nucleus
(Kabashima et al., 2003; Arden et al., 2012; Dentin et al., 2012;
Díaz-Moralli et al., 2012). Besides, a recent report demonstrated that
ketone bodies, increasing the binding of 14-3-3 proteins to ChREBP
and preventing importin-α/ChREBP interaction, impaired the nuclear
import of ChREBP in primary rat hepatocytes (Nakagawa et al., 2013).
Althoughwehave not addressed the role of these proteins in the subcel-
lular localization of ChREBP with aging, our data demonstrate that
serum ketone bodies levels per se are not able to inhibit the nuclear lo-
calization of ChREBP in the liver of overnight and/or prolonged fasted
old rats. Thus, it is plausible that importin-α and/or 14-3-3 proteins
could be altered in old rats impairing the subcellular translocation of
18 A. Salamanca et al. / Experimental Gerontology 69 (2015) 9–19ChREBP in the liver. While this suggestion needs further investigation,
our data strongly suggest that the adaptation of ChREBP in response to
changes in the nutritional state and ketone body levels is impaired
with aging (Fig. 7).
In conclusion, the results presented here demonstrate that in fasted,
low insulin, old rats, Foxo1 and Foxa2 are localized in the cytoplasm,
with a parallel decrease in CPT-1a gene expression and ketone body
levels, probably reﬂecting a reduced mitochondrial long chain fatty
acid oxidation and ketogenesis with aging. Besides, we demonstrate a
sustained nuclear localization of ChREBP in livers from old rats, even
after prolonged fasting, and a signiﬁcant up-regulation of their lipogenic
target genes ACC-α and FAS, favoring hepatic lipid deposition not asso-
ciated, at least at this stage, with the development of hepatic insulin re-
sistance. Although it is a matter of controversy whether age-dependent
liver steatosis might be secondary to increased adiposity and/or insulin
resistance, or to aging per se, or to all of these risk factors, our data sug-
gest that the adaptation of key transcription factors involved in lipid
metabolism, in response to changes in the nutritional state, is impaired
in old rats, and this might contribute to the development of hepatic
steatosis with aging.
Supplementary data to this article can be found online at http://dx.
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